Has the cease-fire rally pushed stocks too high, too quickly?

by News Feed Editor | Apr 9, 2026 | Stock Market

Here’s what a handful of investing professionals say about the market’s rapid recovery — and the fragile Middle East truce. Article Attribution | Read More at Article Source

The stock-market correction isn’t over yet. Here’s why the Iran cease-fire is actually a bad omen.

by News Feed Editor | Apr 9, 2026 | Stock Market

Market timers are too bullish about the outcome of the war — and May marks the start of the worst six-month stretch for markets historically. Article Attribution | Read More at Article Source

The Cassidy-Kaine proposal does virtually nothing to solve Social Security’s financial problems

by News Feed Editor | Apr 9, 2026 | Stock Market

Social Security needs modest revenue increases and benefit cuts — not extreme borrowing. Article Attribution | Read More at Article Source

Your grocery bill will be the next casualty of the Iran war. Make these investment moves now to counter food inflation.

by News Feed Editor | Apr 9, 2026 | Stock Market

Four food-supply chokeholds are squeezing investor portfolios. Here’s what to do before your grocery bill proves it in October. Article Attribution | Read More at Article Source

The shaky Trump-Iran cease-fire means being ready to exit any ‘war’s over’ stock-market rally

by News Feed Editor | Apr 9, 2026 | Stock Market

These signals for investors will make or break the truce — and oil prices. Article Attribution | Read More at Article Source

Here’s how much weight-loss drugs Wegovy, Zepbound and Foundayo cost — and how to pick the best GLP-1 for you

by News Feed Editor | Apr 9, 2026 | Stock Market

The GLP-1 market is growing fast. Here’s how much the most popular medications will cost you. Article Attribution | Read More at Article Source